Marjac - The hipocracy is astounding. That's real rich for these companies, who couldn't care less about destroying a company with one product to sell. What do they expect? An unbiased fair court would look at the dynamics at play here and say, "wait a minute, who the f**k is being the predator monopolist here?" We haven't once, ever, seen deference given to Amrn's single drug disadvantage, and what is required to bring a drug to market, and turn positive cash flow. The piling on has been relentless.
Tell me that's normal.
ILT